Position in ANNX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$23,600,371
+$15,540,356 QoQ
Shares Held
4,259,995
+165.3% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 98.74185298339552.ToString("F0")%
Shared 0.ToString("F0")%
None 1.2581470166044795.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$1,225,000
PutShares
250,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. ANNX ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ANNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,600,371 | 4,259,995 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,060,015 | 1,605,581 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,947,620 | 1,294,302 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,486,707 | 1,452,795 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,004,736 | 1,038,724 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $153,591 | 29,940 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $989,586 | 167,160 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $321,243 | 65,560 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $1,225,000 | 250,000 | Put | Defined | 2024-08-14 | |
| 2024-03-31 | $544,102 | 75,886 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $233,010 | 51,324 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $108,280 | 45,882 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $165,801 | 47,103 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $168,409 | 43,743 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $46,207 | 8,938 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $42,572 | 6,889 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,960 | 8,478 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $146,293 | 53,588 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,107,025 | 96,347 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $181,092 | 9,731 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $242,386 | 10,768 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $259,579 | 9,324 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $70,459 | 2,815 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $112,394 | 3,718 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||